Skip to main content
Redox Biology logoLink to Redox Biology
. 2021 Aug 26;47:102117. doi: 10.1016/j.redox.2021.102117

Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037]

Cláudia M Deus a,b, Susana P Pereira b,c, Teresa Cunha-Oliveira b, José Teixeira b, Rui F Simões a,b, Fernando Cagide d, Sofia Benfeito d, Fernanda Borges d, Nuno Raimundo e,f, Paulo J Oliveira a,
PMCID: PMC8577480  PMID: 34454869

2.3. Cell culture conditions

Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.


Articles from Redox Biology are provided here courtesy of Elsevier

RESOURCES